GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (FRA:K1Z) » Definitions » Institutional Ownership

Chordate Medical Holding AB (FRA:K1Z) Institutional Ownership : 0.00% (As of Apr. 29, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Chordate Medical Holding AB's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Chordate Medical Holding AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Chordate Medical Holding AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Chordate Medical Holding AB Institutional Ownership Historical Data

The historical data trend for Chordate Medical Holding AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Institutional Ownership Chart

Chordate Medical Holding AB Historical Data

The historical data trend for Chordate Medical Holding AB can be seen below:

2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29
Institutional Ownership 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01

Chordate Medical Holding AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Chordate Medical Holding AB Business Description

Traded in Other Exchanges
Address
c/o Regus, Kistagangen 20B, Kista, SWE, 164 40
Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB Headlines

No Headlines